Two Non-Avian Options, Different Price Points
Genvisc 850 and Euflexxa share a key advantage: both are made through bacterial fermentation, making them safe for patients with bird or egg allergies. The differences come down to molecular weight, price, and how much clinical research backs each product.
Side-by-Side Comparison
| Factor | Genvisc 850 | Euflexxa |
|---|---|---|
| Injections | 3 or 5 weekly | 3 weekly |
| Source | Bacterial fermentation | Bacterial fermentation |
| Bird allergy safe | Yes | Yes |
| Molecular weight | 500-730 kDa | 2.4-3.6M Da |
| Volume per injection | 2.5 mL | 2 mL |
| J-Code | J7320 | J7323 |
| Self-pay cost | $400-$700 | $600-$900 |
| Medicare | Yes | Yes |
| Clinical trials | Limited | Extensive (FLEXX trial) |
Genvisc 850: Budget-Friendly Non-Avian HA
Advantages
Considerations
Euflexxa: Clinically Proven Non-Avian HA
Advantages
Considerations
Does Molecular Weight Matter?
This is the core question when comparing these two products. Higher molecular weight HA more closely mimics healthy synovial fluid, which has a molecular weight of about 6-7 million Daltons. Euflexxa’s 2.4-3.6M Da is significantly closer to natural joint fluid than Genvisc 850’s 500-730 kDa.
Some research suggests higher molecular weight correlates with longer-lasting relief, though the clinical differences between mid-range products are debated. What is clear: Euflexxa has more published data supporting its effectiveness.
Making Your Decision
Choose Genvisc 850 if:
- Cost is your top priority
- You want the most affordable non-avian option
- Your insurer reimburses it well
- You’re trying HA therapy for the first time at lowest risk
Choose Euflexxa if:
- You value clinical evidence backing your treatment
- Higher molecular weight matters to you
- You want a product with the FLEXX trial data behind it
- Your insurer covers both at similar out-of-pocket cost
Frequently Asked Questions
Are these products interchangeable?
Not exactly. While both are non-avian HA products, they differ in molecular weight and formulation. Your doctor may have a preference based on their clinical experience. If one hasn’t worked well, switching to the other is reasonable.
Can I switch between Genvisc 850 and Euflexxa?
Yes. After completing a treatment course and waiting the appropriate interval, you can try a different brand. Some patients respond better to one formulation than another.
Which has better Medicare reimbursement?
Both are covered under Medicare Part B. Genvisc 850 sometimes has more favorable reimbursement rates for providers because of its lower acquisition cost, which can make it more widely available at certain clinics.
How long does each one last?
Both typically provide 6 months of relief, though individual responses vary. The FLEXX trial showed Euflexxa maintained statistically significant pain improvement through 26 weeks.
The Bottom Line
Genvisc 850 is the value play: lowest cost, non-avian, Medicare-covered.
Euflexxa is the evidence-backed choice: FLEXX trial data, higher molecular weight, and broader clinical support.
Both are allergy-safe and effective. If your insurer covers both equally, Euflexxa’s stronger data gives it an edge. If cost matters most, Genvisc 850 delivers HA therapy at the best price.
Find HA Injection Providers
Connect with specialists offering non-avian gel injections.
Your information is secure. See our Privacy Policy and Terms of Service.
Thank You!
We've received your request. A provider specialist will contact you within 1-2 business days to help you find the right care.
What happens next?
- 1 We'll verify your insurance coverage
- 2 Match you with quality providers in your area
- 3 Contact you to discuss your options
Questions? Browse our guides:
How to Choose a ProviderTreatment Comparison Updates
Stay informed about knee arthritis treatment options and costs.
Join 10,000+ readers. No spam.